Company intelligence / Profile preview

Dx Biosamples

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Dx Biosamples is a leading provider of fresh and frozen human biospecimens and associated clinical data to support biomedical, biotech, pharmaceutical, diagnostic, and academic research. The company operates an IRB-approved network of clinical collection sites across the US and supplies high-quality samples with comprehensive deidentified clinical data. It is trusted by major pharmaceutical and biotech companies worldwide.

Therapeutic areas: OncologyMetabolic DisordersPulmonologyWomen's HealthImmunologyNeurologyNephrologyInfectious Diseases
Industry: Contract Research Organization

Partnerships

Major pharmaceutical companies (unnamed)Major biotech companies (unnamed)

Beyond the preview

Go deeper on Dx Biosamples.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dx Biosamples.

Explore the full profile